Enzyme MLN

1. Summary

Ranks

Liquidity

91

Developer

-

Social

78

Momentum (beta)

43

Stack Rank™

-

Price

$18.88 +2.4%

Market Cap

$27.48M (#816)

Supply

1.45M / 2.67M

Tags

DeFi Business Platform Finance / Banking Asset Manager Polygon Ecosystem Ethereum Ecosystem DeFiance Capital Portfolio

More Metrics

Price
52W High price	$31.62
52W High date	23rd Mar 2024 (4 months ago)
All Time High (ATH) Date	4th Jan 2018 (6 years ago)
ATH Price	$258.26
% From ATH	-93.38%
All Time Low (ATL) Date	13th Mar 2020 (4 years ago)
ATL Price	$1.79
% From ATL	854.63%

Supply & Trading Volume
Trading Volume (24h)	$3.49M
Total Supply	2.67M
Max Supply	2.67M
Circulating Supply	1.45M

Less Metrics

Description

Overview

Read More

Overview

Enzyme is a fast and cost-effective decentralized asset management platform that allows users to build, scale, and monetize investment strategies in the DeFi (Decentralized Finance) space. It is powered by the MLN token, an ERC-20 utility token that grants access to the protocol and supports its development, maintenance, and marketing.

Features

• Customizable Asset Pools: Users can create and manage customizable vaults that pool up to 20 tokens with determined investment strategies.
• Programmable Risk Management: Users can manage risk through programmable smart contract-enforced measures.
• 24/7 Net Asset Value Reporting: Users have access to real-time NAV reports, ensuring transparency.
• Trustless Trading Delegation: Users can set up smart contract-enforced permissions and trading roles within their organizations.

Operations

• Chain Options: Enzyme Finance supports both Ethereum and Polygon chains, allowing users to choose based on their needs.
• Vault Management: Users can deposit assets to Enzyme vaults, scaled to execute various investment strategies.
• Security Focus: The protocol emphasizes thorough audits on contracts, with strict controls and transparent actions.

History and Governance

• Founding and Rebranding: Enzyme was founded in 2016 as Melon Protocol and rebranded to Enzyme Finance in 2019. Mona El Isa, a former Goldman Sachs executive, and Reto Trinkler, a mathematician, are its founders.
• Decentralized Autonomous Organization (DAO): The platform is managed by the Enzyme Council, ensuring decentralized governance and decision-making.

Token Details

• MLN Token: Total supply of 2,365,228 tokens with 300,600 MLN tokens released annually, primarily allocated to projects and contributors.
• Token Usage: MLN tokens are used for access fees (25 basis points of assets under management) and are automatically burned upon collection.

Show Less